Cover Image
Market Research Report

Pharma-Payer Partnerships in Emerging Markets

Published by Datamonitor Healthcare Product code 570533
Published Content info 72 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pharma-Payer Partnerships in Emerging Markets
Published: August 14, 2017 Content info: 72 Pages
Description

Payer partnerships are becoming widespread as emerging markets become wealthier, but access challenges remain. Partnerships with proven success include "strategic philanthropy," patient access programs, tiered pricing, and service support models. Many of the most successful strategies are hybrids of two or more "pure" partnership archetypes.

This analysis is a survey of recent industry experience with payer partnerships in emerging markets, using case studies and real-world exemplars to illustrate best practice. While there is no "one size fits all" approach to partnering in emerging markets, Datamonitor Healthcare has considered in each case how best to address payer needs that cannot be served by the routine course of business.

This analysis covers self-pay markets, partially reimbursed, and reimbursed emerging markets. Pharmaceutical companies that can overcome payer resistance, and take a proactive approach, can reap significant rewards from innovative partnerships in challenging, high-growth markets.

Table of Contents
Product Code: DMKC0176385

TABLE OF CONTENTS

5. EXECUTIVE SUMMARY

  • Partnerships with payers facilitate access in emerging markets
  • Partnerships with payers take many forms, depending on funding source
  • Customization is key for successful partnerships in self-pay markets
  • Even in reimbursed emerging markets, paying for outcomes is rare
  • The most successful partnerships are driven at the local level

7. THE PHARMA-PAYER PARTNERSHIPS LANDSCAPE

  • Payer partnerships are unlocking emerging-market opportunities
  • The market structure shapes the partnership
  • Bibliography

12. PARTNERSHIPS IN SELF-PAY EMERGING MARKETS

  • Self-pay markets: summary of partnership options
  • Donation partnerships
  • Tiered pricing
  • Continuous treatment programs
  • Complementary health insurance
  • Bibliography

41. PARTNERSHIPS IN REIMBURSED EMERGING MARKETS

  • Service support can boost access in reimbursed markets
  • Real-world evidence is gaining traction in emerging markets
  • Risk sharing in reimbursed emerging markets
  • Technology transfer in emerging markets
  • Bibliography

65. CRITICAL SUCCESS FACTORS FOR PARTNERSHIPS IN EMERGING MARKETS

  • Aligning partnerships with local goals and capabilities is key
  • Assessing risk-reward in partnering options

70. APPENDIX

  • About the author
  • Methodology

LIST OF FIGURES

  • Figure 1: Payer partnership options in emerging markets
  • Figure 2: Donation/tiered pricing archetype
  • Figure 3: Novartis access differentiated strategy
  • Figure 4: Continuous treatment program archetype
  • Figure 5: Discount card archetype (variant of CTP model)
  • Figure 6: Complementary insurance partnership archetype
  • Figure 7: Stakeholder map of Turkey
  • Figure 8: Outcomes-based risk sharing archetype
  • Figure 9: Stakeholder map of Mexico
  • Figure 10: Technology transfer archetype (Brazilian Partnerships for Productive Development model)
  • Figure 11: Requirements for emerging-market payer partnerships

LIST OF TABLES

  • Table 1: Risk-benefit matrix: partnerships in self-pay markets
  • Table 2: Case study 1: The Max Foundation
  • Table 3: Case study 2: Novartis Philippines and Roche Egypt
  • Table 4: Case study 3: Sanofi's emerging-market partnerships
  • Table 5: Case study 4: PAPs in Argentina
  • Table 6: Case study 5: Complementary insurance programs in China
  • Table 7: Case study 6: Payer support programs in Latin America
  • Table 8: Case study 7: Risk sharing in three Latin American markets
  • Table 9: Case study 8: Technology transfer programs in Brazil
  • Table 10: Options for payer partnerships by market archetype
Back to Top